Symbol
| BEX2
| contributors: mct/npt - updated : 20-03-2018
|
HGNC name
| brain expressed X-linked 2
|
HGNC id
| 30933
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --over
|  
|
in a subset of primary breast cancers, mediating nerve growth factor/nuclear factor-kappaB inhibition of apoptosis in breast cancer cell lines (Naderi 2007) | tumoral
|  
|  
| --over
|  
|
in glioma tissues | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
cancer | brain | glioma/neuroblstoma | |
contributes to glioma development by regulating the JUN NH2-terminal kinase pathway | cancer | digestive | colon | |
BEX2 as a potential candidate target for the treatment of colorectal cancer (CRC) | cancer | brain | | |
potential target for novel therapies for ependymoma in children |
| | | |
| Bex2-deficient mice were viable and fertile under laboratory growth conditions showing no obvious phenotypic abnormalities 3) |